Education
About Us
Working with TipRanks
Follow Us
Bernard Cassidy Insider Profile
4 Followers
Bernard Cassidy, GC & Secretary at Juno Therapeutics, holds 112.99K shares in Sana Biotechnology (Ticker: SANA), holds 0.00 shares in Juno Therapeutics (Ticker: JUNO), holds 41.25K shares in Adeia (Ticker: ADEA).
Bernard Cassidy Juno Therapeutics (JUNO)GC & Secretary
Juno Therapeutics (JUNO)
GC & Secretary
Not Ranked
Bernard Cassidy has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Bernard Cassidy holds in companies
Most Profitable Insider Trade
The most profitable trade made by Bernard Cassidy
Bernard Cassidy's Trading History
Juno Therapeutics
Mar 07, 2018
―
Uninformative Sell
2.82M
$0.00
Sana Biotechnology
Mar 10, 2025
EVP & GC
Uninformative Buy
21.18K
$573.99K
Adeia
Mar 07, 2013
EVP & GC, TIPC President
Uninformative Sell
53.47K
$529.65K
List of latest transactions for each holding click on a transaction to see Bernard Cassidy's performance on stock
You May Also Like
Bernard Cassidy insider profile FAQ
What is the percentage of profitable transactions made by Bernard Cassidy?
The percentage of profitable transactions made by Bernard Cassidy is ―.
What is the average return per transaction made by Bernard Cassidy?
The average return per transaction made by Bernard Cassidy is ―.
What stocks does Bernard Cassidy hold?
Bernard Cassidy holds: JUNO, SANA, ADEA stocks.
What was Bernard Cassidy’s latest transaction?
Bernard Cassidy latest transaction was an Uninformative Buy of $21.18K.
What was Bernard Cassidy's most profitable transaction?
Bernard Cassidy’s most profitable transaction was an Informative Sell of ADEA stock on September 9, 2009. The return on the trade was 40.00%.
What is Bernard Cassidy's role in Juno Therapeutics?
Bernard Cassidy's role in Juno Therapeutics is GC & Secretary.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.